The controversy over the cost of EpiPens is prompting a bipartisan effort to force drugmakers to detail their costs before they increase prices by more than 10 percent.
Republican Sen. John McCain of Arizona and Democrats, Sen. Tammy Baldwin of Wisconsin and Rep. Jan Schakowsky of Illinois said in a statement Thursday that the effort will cut through opaque pricing practices and provide information about treatments that are sometimes developed with taxpayer dollars.
Read Full Article »